Crossref
ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities
Generics and Biosimilars Initiative Journal · 15.08.2012 · 1 (3-4) · 142-144
DOI: 10.5639/gabij.2012.0103-4.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Generics and Biosimilars Initiative Journal, erschienen am 15.08.2012. Verfasst von Keith McDonald. Die Arbeit wurde bisher 49-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
McDonald, K. (2012). ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities. Generics and Biosimilars Initiative Journal, 1(3-4), 142-144. https://doi.org/10.5639/gabij.2012.0103-4.025
Vancouver
McDonald K. ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities. Generics and Biosimilars Initiative Journal. 2012;1(3-4):142-144. doi:10.5639/gabij.2012.0103-4.025
BibTeX
@article{McDonald2012,
author = {McDonald, Keith},
title = {ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities},
journal = {Generics and Biosimilars Initiative Journal},
year = {2012},
volume = {1},
number = {3-4},
pages = {142--144},
doi = {10.5639/gabij.2012.0103-4.025}
}
EUVIMED